Trial
NCT00891904
Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Head and Neck Cancer
Intervention
cetuximab
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-14